Lysophosphatidic Acid Induces Chemotaxis, Oxygen Radical Production, CD11b Up-Regulation, Ca2+ Mobilization, and Actin Reorganization in Human Eosinophils via Pertussis Toxin-Sensitive G Proteins

Journal of Immunology

Volumn 172, Issue 7, 2004, Pages 4480-4485

  Idzko, Marco ^a   Laut, Martin ^a   Panther, Elisabeth ^a   Sorichter, Stephan ^a   Dürk, Thorsten ^a   Fluhr, Joachim W ^b   Herouy, Yared ^a   Mockenhaupt, Maja ^a   Myrtek, Daniel ^a   Elsner, Peter ^b   Norgauer, Johannes ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Department of Dermatology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD11B ANTIGEN; CHEMOTAXIN; DIACYLGLYCEROL; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; OXYGEN RADICAL; PERTUSSIS TOXIN; PHOSPHOLIPASE A2; PYROPHOSPHORIC ACID DERIVATIVE;

ACTIN POLYMERIZATION; ARTICLE; ATOPY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; EFFECTOR CELL; ENDOTHELIAL DIFFERENTIATION GENE 2; ENDOTHELIAL DIFFERENTIATION GENE 7; EOSINOPHIL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 12144287051     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.7.4480     Document Type: Article

References (42)

1. Bruijnzeel, P. 1994. Eosinophil tissue mobilization in allergic disorders. Ann. Acad. Sci. 725:259.
2. +) T cells and eosinophils in allergy and asthma. Am. Rev. Respir. Dis. 145:S22.
3. Walker, C., M. K. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:935.
4. Gounni, A. S., B. Lamkhioued, E. Delaporte, A. Dubost, J. P. Kinet, A. Capron, and M. Capron. 1994. The high-affinity IgE receptor on eosinophils: from allergy to parasites. J. Allergy Clin. Immunol. 94:1214.
5. Weller, P. F. 1992. Roles of eosinophils in allergy. Curr. Opin. Immunol. 4:782.
6. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85.
7. Weber, M., and C. A. Dahinden. 1995. Basophil and eosinophil activation by CC chemokines. Int. Arch. Allergy Immunol. 107:148.
8. Valone, F. H. 1980. Modulation of human neutrophil and eosinophil polymorphonuclear leukocyte chemotaxis: an analytical review. Clin. Immunol. Immunopathol. 15:52.
9. Nagy, L., T. H. Lee, E. J. Goetzl, W. C. Pickett, and A. B. Kay. 1982. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin. Exp. Immunol. 47:541.
10. Wardlaw, A. J., R. Moqbel, O. Cromwell, and A. B. Kay. 1986. Platelet activating factor: a potent chemotactic and chemokinetic factor for eosinophils. J. Clin. Invest. 78:1701.
11. ++ mobilization and actin reorganization in human eosinophils. Blood 95:973.
12. Tenscher, K., B. Metzner, C. Hofmann, E. Schöpf, and J. Norgauer. 1997. The monocyte chemotactic protein-4 (MCP-4) induces oxygen radical production, actin reorganization and CD11b upregulation via a pertussis toxin-sensitive G-protein in human eosinophils. Biochem. Biophys. Res. Commun. 240:32.
13. Kapp, A., G. Zeck-Kapp, W. Czech, and E. Schöpf. 1994. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J. Invest. Dermatol. 102:906.
14. Baggiolini, M., and C. A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today 15:127.
15. i-proteins mediate N-formyl-peptide receptor signal transduction in human leukemia (HL-60) cells. J. Biol. Chem. 264:21470.
16. Camps, M., A. Carozzi, P. Schnabel, P. Scheer, P. J. Parker, and P. Gierschik. 1992. Isozyme-selective stimulation of phospholipase C-β by G-protein β-γ subunits. Nature 360:684.
17. Ren, X. D., W. B. Kiossses, and M. A. Schwartz. 1999. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:578.
18. Cunningham, C. C., R. Vegners, R. Bucki, M. Funaki, N. Korde, J. H. Hartwig, T. P. Stossel, and P. A. Janmey. 2001. Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly. J. Biol. Chem. 276:43390.
19. Li, Z., H. Jiang, W. Xie, Z. Zhang, A. V. Smrcka, and D. Wu. 2000. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 287:1046.
20. Moolenar, W. H. 2000. Development of our current understanding of bioactive lysophospholipids. In Lysophospholipids and eicosanoids in biology and pathophysiology. E. Goetzl and K. Lynch, eds. Ann. NY Acad. Sci. 905:1.
21. Moolenaar, W. H. 1999. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 253:230.
22. 2 protein interaction. J. Clin. Invest. 102:1152.
23. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919.
24. Eichholtz, T., K. Jalink, I. Fahrenfort, and W. H. Moolenaar. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291:677.
25. Gaits, F., O. Fourcade, F. LeBalle, G. Gueguen, B. Gaige, A. Gassama-Diage, J. Fauvel, J. P. Salles, G. Mauco, M. F. Simon, and H. Chap H. 1997. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett. 410:54.
26. Goetzl, E., and K. Lynch. 2000. The omnific lysophospholipid growth factors: In Lysophospholipids and eicosanoids in biology and pathophysiology. Ann. NY Acad. Sci. 905:11.
27. Zheng, Y., J. Voice, K. Kong, and E. J. Goetzl. 2000. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. FASEB J. 14:2387.
28. Goetzl, E. J., Y. Kong, and J. K. Voice. 2000. Cutting edge: Differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J. Immunol. 16:4996.
29. Zheng, Y., Y. Kong, and E. J. Goetzl. 2001. Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a matrigel model basement membrane. J. Immunol. 166:2317.
30. Rosskopf, D., W. Daelman, S. Busch, M. Schürks, K. Hartung, A. Kribben, M. Michel, and W. Siefert. 1998. Growth factor-like action of lysophosphatidic acid on human B lymphoblasts. Am. J. Physiol. 274:C1573.
31. Rizza, C., N. Leitinger, J. Yue, D. J. Fischer, D. A. Wang, P. T. Shih, H. Lee, G. Tigyi, and J. A. Berliner. 1999. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79:1227.
32. Panther, E., M. Idzko, S. Corinti, D. Ferrari, Y. Herouy, M. Mockenhaupt, S. Dichmann, P. Gebicke-Haerter, F. Di Virgilio, G. Girolomoni, and J. Norgauer. 2001. The influence of lysophosphatidic acid on the functions of human dendritic cells. J. Immunol. 169:4129.
33. Contos, J. J., I. Ishii, and J. Chun. 2000. Lysophosphatidic acid receptors. Mol. Pharmacol. 58:1188.
34. Swarthout, J. T., and H. W. Walling. 2000. Lysophosphatidic acid: receptors, signaling and survival. Cell. Mol. Life Sci. 57:1978.
35. Ishii, I., J. J. Contos, N. Fukushima, and J. Chun. 2000. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 58:895.
36. αi protein. J. Neurochem. 75:1575.
37. 2 and arachidonate increase in bronchoalveolar lavage fluid inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 155:421.
38. 2 from human nasal lavage. Am. J. Respir. Cell. Mol. Biol. 11:108.
39. Chilton, F. H., F. J. Averill, W. C. Hubbard, A. N. Fonteh, M. Triggiani, and M. C. Liu. 1996. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183:2235.
40. Fischer, D. J., N. Nusser, T. Virag, K. Yokoyama, D. Wang, D. L. Baker, D. Bautista, A. L. Parrill, and G. Tigyi. 2001. Short-chain phosphatides are subtype-selective antagonists of lysophosphatidic acid receptors. Mol. Pharmacol. 60:776.
41. Tigyi, G. 2001. Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family. Mol. Pharmacol. 60:1161.
42. 2 activate selective functions in human eosinophils. J. Immunol. 170:3279.